Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA & RNA Banking Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Feb, 2023
- Report ID: sector-report-00142
- Format: Electronic (PDF)
- Number of Pages: 250
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2 Market Definitions
- 2.1 Definitions
Chapter 3 Executive Summary
- 3.1 Market Summary
Chapter 4 Global Biobanking Industry Variables, Trends, & Scope
- 4.1 Biobanking Industry Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration And Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Continuous increase in COVID-19 cases
- 4.4.2 Increased focus on precision medicine and genetic testing
- 4.4.3 Changes in biobanking operations & automation of biobanks
- 4.4.4 Increase in the number of clinical trials globally
- 4.4.5 Growing industry and research collaborations
- 4.4.6 Technological advancement involving cell banking
- 4.4.7 Patent expiration of blockbuster biologics
- 4.4.8 Growing R&D investments in biotechnology sector
- 4.5 Market Restraint Analysis
- 4.5.1 Disruptions in supply chain management due to COVID-19
- 4.5.2 Challenges in sharing biobanking data & limited access to biospecimens
- 4.5.3 Sustainability challenges for biobanks
- 4.6 Value Chain Analysis
- 4.6.1 Value Chain Analysis/Route To Market
- 4.7 Consumer Behavior Analysis
- 4.8 Major Deals and Strategic Alliances Analysis
- 4.8.1 New product launch
- 4.8.1.1 Mergers and acquisitions
- 4.8.1.2 Expansion
- 4.8.1.3 Partnerships
- 4.8.1.4 Marketing & promotions
- 4.8.1.5 Market entry strategies
- 4.8.2 Mergers And Deals
- 4.9 Biobanks Market Analysis Tools
- 4.9.1 Industry Analysis - Porter’s
- 4.9.2 SWOT Analysis, By PEST
- 4.10 Cell Banking Outsourcing Market Analysis Tools
- 4.10.1 Industry Analysis - Porter’s
- 4.10.2 SWOT Analysis, By PEST
- 4.11 Cord Blood Banking Services Market Analysis Tools
- 4.11.1 Industry Analysis - Porter’s
- 4.11.2 SWOT Analysis, By PEST
- 4.12 DNA & RNA Banking Services Market Analysis Tools
- 4.12.1 Industry Analysis - Porter’s
- 4.12.2 SWOT Analysis, By PEST
Chapter 5 Biobanks Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 5.1 Biobanks Market: Product Movement Analysis
- 5.2 Biobanking Equipment
- 5.2.1 Biobanking equipment market, 2018 - 2030 (USD Million)
- 5.2.2 Temperature control systems
- 5.2.2.1 Temperature control systems market, 2018 - 2030 (USD Million)
- 5.2.2.2 Freezers & refrigerators
- 5.2.2.2.1 Freezers & refrigerators market, 2018 - 2030 (USD Million)
- 5.2.2.3 Cryogenic storage systems
- 5.2.2.3.1 Cryogenic storage systems market, 2018 - 2030 (USD Million)
- 5.2.2.4 Thawing equipment
- 5.2.2.4.1 Thawing equipment market, 2018 - 2030 (USD Million)
- 5.2.3 Incubators & centrifuges
- 5.2.3.1 Incubators & centrifuges market, 2018 - 2030 (USD Million)
- 5.2.4 Alarms & monitoring systems
- 5.2.4.1 Alarms & monitoring systems market, 2018 - 2030 (USD Million)
- 5.2.5 Accessories & other equipment
- 5.2.5.1 Accessories & other equipment market, 2018 - 2030 (USD Million)
- 5.3 Biobanking Consumables
- 5.3.1 Biobanking consumables market, 2018 - 2030 (USD Million)
- 5.4 Laboratory Information Management Systems
- 5.4.1 Laboratory information management systems market, 2018 - 2030 (USD Million)
Chapter 6 Biobanks Market - Segment Analysis, by Service, 2018 - 2030 (USD Million)
- 6.1 Biobanks Market: Service Movement Analysis
- 6.2 Biobanking & Repository
- 6.2.1 Biobanking & repository market, 2018 - 2030 (USD Million)
- 6.3 Lab Processing
- 6.3.1 Lab processing market, 2018 - 2030 (USD Million)
- 6.4 Qualification/Validation
- 6.4.1 Qualification/ validation market, 2018 - 2030 (USD Million)
- 6.5 Cold chain logistics
- 6.5.1 Cold chain logistics market, 2018 - 2030 (USD Million)
- 6.6 Other services
- 6.6.1 Other services market, 2018 - 2030 (USD Million)
Chapter 7 Biobanks Market - Segment Analysis, by Biospecimen Type, 2018 - 2030 (USD Million)
- 7.1 Biobanks Market: Biospecimen Type Movement Analysis
- 7.2 Human Tissues
- 7.2.1 Human tissues market, 2018 - 2030 (USD Million)
- 7.3 Organs
- 7.3.1 Organs market, 2018 - 2030 (USD Million)
- 7.4 Stem Cells
- 7.4.1 Stem cells market, 2018 - 2030 (USD Million)
- 7.4.2 Adult stem cells
- 7.4.2.1 Adult stem cells market, 2018 - 2030 (USD Million)
- 7.4.3 Embryonic stem cells
- 7.4.3.1 Embryonic stem cells market, 2018 - 2030 (USD Million)
- 7.4.4 IPS cells
- 7.4.4.1 IPS cells market, 2018 - 2030 (USD Million)
- 7.4.5 Other stem cells
- 7.4.5.1 Other stem cells market, 2018 - 2030 (USD Million)
- 7.5 Other Biospecimens
- 7.5.1 Other biospecimens market, 2018 - 2030 (USD Million)
Chapter 8 Biobanks Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 8.1 Biobanks Market: Type Movement Analysis
- 8.2 Physical/Real Biobanks
- 8.2.1 Physical/Real Biobanks market, 2018 - 2030 (USD Million)
- 8.2.2 Tissue biobanks
- 8.2.2.1 Tissue biobanks market, 2018 - 2030 (USD Million)
- 8.2.3 Population based biobanks
- 8.2.3.1 Population based biobanks market, 2018 - 2030 (USD Million)
- 8.2.4 Genetic (DNA/RNA)
- 8.2.4.1 Genetic (DNA/RNA) market, 2018 - 2030 (USD Million)
- 8.2.5 Disease based biobanks
- 8.2.5.1 Disease based biobanks market, 2018 - 2030 (USD Million)
- 8.3 Virtual Biobanks
- 8.3.1 Virtual biobanks market, 2018 - 2030 (USD Million)
Chapter 9 Biobanks Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 9.1 Biobanks Market: Type Movement Analysis
- 9.2 Therapeutics
- 9.2.1 Therapeutics market, 2018 - 2030 (USD Million)
- 9.3 Drug Discovery & Clinical Research
- 9.3.1 Drug discovery & clinical research market, 2018 - 2030 (USD Million)
- 9.4 Clinical Diagnostics
- 9.4.1 Clinical diagnostics market, 2018 - 2030 (USD Million)
- 9.5 Other Application
- 9.5.1 Other application market, 2018 - 2030 (USD Million)
Chapter 10 Cell Banking Outsourcing Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 10.1 Cell Banking Outsourcing Market: Type Movement Analysis
- 10.2 Master cell banking
- 10.2.1 Master cell banking market, 2018 - 2030 (USD Million)
- 10.3 Working cell banking
- 10.3.1 Working cell banking market, 2018 - 2030 (USD Million)
- 10.4 Viral cell banking
- 10.4.1 Viral cell banking market, 2018 - 2030 (USD Million)
Chapter 11 Cell Banking Outsourcing Market - Segment Analysis, by Cell Type, 2018 - 2030 (USD Million)
- 11.1 Cell Banking Outsourcing Market: Cell Type Movement Analysis
- 11.2 Stem Cell
- 11.2.1 Stem cell market, 2018 - 2030 (USD Million)
- 11.2.2 Cord cell banking
- 11.2.2.1 Cord cell banking market, 2018 - 2030 (USD Million)
- 11.2.3 Embryonic stem cell banking
- 11.2.3.1 Embryonic stem cell banking market, 2018 - 2030 (USD Million)
- 11.2.4 Adult stem cell banking
- 11.2.4.1 Adult stem cell banking market, 2018 - 2030 (USD Million)
- 11.2.5 Dental stem cell banking
- 11.2.5.1 Dental stem cell banking market, 2018 - 2030 (USD Million)
- 11.2.6 IPS stem cell banking
- 11.2.6.1 IPS stem cell banking market, 2018 - 2030 (USD Million)
- 11.3 Non-stem cell
- 11.3.1 Non-stem cell market, 2018 - 2030 (USD Million)
Chapter 12 Cell Banking Outsourcing Market - Segment Analysis, by Phase, 2018 - 2030 (USD Million)
- 12.1 Cell Banking Outsourcing Market: Phase Movement Analysis
- 12.2 Bank Storage
- 12.2.1 Bank storage market, 2018 - 2030 (USD Million)
- 12.2.2 Master cell bank prep
- 12.2.2.1 Master cell bank prep market, 2018 - 2030 (USD Million)
- 12.2.3 Working cell bank prep
- 12.2.3.1 Working cell bank prep market, 2018 - 2030 (USD Million)
- 12.2.4 Cell storage stability testing
- 12.2.4.1 Cell storage stability testing market, 2018 - 2030 (USD Million)
- 12.3 Bank Characterization & Testing
- 12.3.1 Bank characterization & testing market, 2018 - 2030 (USD Million)
- 12.3.2 Safety testing
- 12.3.2.1 Safety testing market, 2018 - 2030 (USD Million)
- 12.3.3 Gene expression testing
- 12.3.3.1 Gene expression testing market, 2018 - 2030 (USD Million)
- 12.3.4 Karyology testing
- 12.3.4.1 Karyology testing market, 2018 - 2030 (USD Million)
- 12.3.5 Gene sequencing testing
- 12.3.4.1 Gene sequencing testing market, 2018 - 2030 (USD Million)
- 12.4 Bank Preparation
- 12.4.1 Bank preparation market, 2018 - 2030 (USD Million)
- 12.4.2 Master cell bank prep
- 12.4.2.1 Master cell bank prep market, 2018 - 2030 (USD Million)
- 12.4.3 Working cell bank prep
- 12.4.3.1 Working cell bank prep market, 2018 - 2030 (USD Million)
Chapter 13 Cord Blood Banking Services Market - Segment Analysis, by Bank Type, 2018 - 2030 (USD Million)
- 13.1 Cord Blood Banking Services Market: Bank Type Movement Analysis
- 13.2 Private
- 13.2.1 Private market, 2018 - 2030 (USD Million)
- 13.3 Public
- 13.3.1 Public market, 2018 - 2030 (USD Million)
- 13.4 Hybrid
- 13.4.1 Hybrid market, 2018 - 2030 (USD Million)
Chapter 14 DNA & RNA Banking Services Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 14.1 DNA & RNA Banking Services Market: Type Movement Analysis
- 14.2 Transportation Service
- 14.2.1 Transportation service market, 2018 - 2030 (USD Million)
- 14.3 Processing Service
- 14.3.1 Processing service market, 2018 - 2030 (USD Million)
- 14.4 Storage Service
- 14.4.1 Storage service market, 2018 - 2030 (USD Million)
- 14.3 Quality Control Service
- 14.3.1 Quality control service market, 2018 - 2030 (USD Million)
- 14.4 Data Storage
- 14.4.1 Data storage market, 2018 - 2030 (USD Million)
- 14.5 Others
- 14.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 15 DNA & RNA Banking Services Market - Segment Analysis, by Specimen Type, 2018 - 2030 (USD Million)
- 15.1 DNA & RNA Banking Services Market: Specimen Type Movement Analysis
- 15.2 Blood
- 15.2.1 Blood market, 2018 - 2030 (USD Million)
- 15.3 Buccal swabs & hair follicles
- 15.3.1 Buccal swabs & hair follicles market, 2018 - 2030 (USD Million)
- 15.4 Others
- 15.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 16 DNA & RNA Banking Services Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 16.1 DNA & RNA Banking Services Market: Application Movement Analysis
- 16.2 Therapeutics
- 16.2.1 Therapeutics market, 2018 - 2030 (USD Million)
- 16.3 Drug Discovery & Clinical Research
- 16.3.1 Drug discovery & clinical research market, 2018 - 2030 (USD Million)
- 16.4 Clinical Diagnostics
- 16.4.1 Clinical Diagnostics market, 2018 - 2030 (USD Million)
- 16.5 Others
- 16.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 17 DNA & RNA Banking Services Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
- 17.1 DNA & RNA Banking Services Market: End-use Movement Analysis
- 17.2 Academic Research
- 17.2.1 Academic research market, 2018 - 2030 (USD Million)
- 17.3 Pharmaceutical & Biotechnology Companies
- 17.3.1 Pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
- 17.4 Hospitals & Diagnostic Centers
- 17.4.1 Hospitals & diagnostic centers market, 2018 - 2030 (USD Million)
- 17.5 Others
- 17.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 18 Biobanks Industry - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 18.1 Biobanks Industry: Regional Movement Analysis
- 18.2 North America
- 18.2.1 North America
- 18.2.2 North America Biobanks market. 2018 - 2030 (USD Million)
- 18.2.3 U.S.
- 18.2.3.1 U.S. Biobanks market. 2018 - 2030 (USD Million)
- 18.2.4 Canada
- 18.2.4.1 Canada Biobanks market. 2018 - 2030 (USD Million)
- 18.3 Europe
- 18.3.1 Europe
- 18.3.2 Europe Biobanks market. 2018 - 2030 (USD Million)
- 18.3.3 UK
- 18.3.3.1 UK Biobanks market. 2018 - 2030 (USD Million)
- 18.3.4 Germany
- 18.3.4.1 Germany Biobanks market. 2018 - 2030 (USD Million)
- 18.3.5 Spain
- 18.3.5.1 Spain Biobanks market. 2018 - 2030 (USD Million)
- 18.3.6 France
- 18.3.6.1 France Biobanks market. 2018 - 2030 (USD Million)
- 18.3.7 Italy
- 18.3.7.1 Italy Biobanks market. 2018 - 2030 (USD Million)
- 18.4 Asia Pacific
- 18.4.1 Asia Pacific
- 18.4.2 Asia Pacific Biobanks market. 2018 - 2030 (USD Million)
- 18.4.3 Japan
- 18.4.3.1 Japan Biobanks market. 2018 - 2030 (USD Million)
- 18.4.4 China
- 18.4.4.1 China Biobanks market. 2018 - 2030 (USD Million)
- 18.4.5 India
- 18.4.5.1 India Biobanks market. 2018 - 2030 (USD Million)
- 18.4.6 South Korea
- 18.4.6.1 South Korea Biobanks market. 2018 - 2030 (USD Million)
- 18.4.7 Australia
- 18.4.7.1 Australia Biobanks market. 2018 - 2030 (USD Million)
- 18.5 Latin America
- 18.5.1 Latin America
- 18.5.2 Latin America Biobanks market. 2018 - 2030 (USD Million)
- 18.5.3 Brazil
- 18.5.3.1 Brazil Biobanks market. 2018 - 2030 (USD Million)
- 18.5.4 Mexico
- 18.5.4.1 Mexico Biobanks market. 2018 - 2030 (USD Million)
- 18.5.5 Argentina
- 18.5.5.1 Argentina Biobanks market. 2018 - 2030 (USD Million)
- 18.6 Middle East and Africa
- 18.6.1 Middle East & Africa, SWOT Analysis
- 18.6.2 Middle-East And Africa Biobanks market. 2018 - 2030 (USD Million)
- 18.6.3 South Africa
- 18.6.3.1 South Africa Biobanks market. 2018 - 2030 (USD Million)
- 18.6.4 UAE
- 18.6.4.1 UAE Biobanks market. 2018 - 2030 (USD Million)
- 18.6.5 Saudi Arabia
- 18.6.5.1 Saudi Arabia Biobanks market. 2018 - 2030 (USD Million)
Chapter 19 Competitive Analysis
- 19.1 Recent Developments & Impact Analysis, By Key Market Participants
- 19.1.1 Ansoff Matrix
- 19.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
- 19.1.3 Innovators
- 19.2 Vendor Landscape
- 19.2.1 List Of Key Distributors And Channel Partners
- 19.2.2 Global Biobanking Industry: Key Company Market Share Analysis, 2021
- 19.3 Public Companies
- 19.3.1 Company Market Position Analysis
- 19.3.2 Competitive Dashboard Analysis
- 19.3.3 Strategic Framework
- 19.4 Private Companies
- 19.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 19.4.2 Regional Network Map
- 19.5 Company Profiles
- 19.5.1 DANAHER CORPORATION
- 19.5.1.1 Company Overview
- 19.5.1.2 Financial Performance
- 19.5.1.3 Product Benchmarking
- 19.5.1.4 Strategic Initiatives
- 19.5.2 Tecan Trading AG.
- 19.5.2.1 Company Overview
- 19.5.2.2 Financial Performance
- 19.5.2.3 Product Benchmarking
- 19.5.2.4 Strategic Initiatives
- 19.5.3 THERMO FISHER SCIENTIFIC, INC.
- 19.5.3.1 Company Overview
- 19.5.3.2 Financial Performance
- 19.5.3.3 Product Benchmarking
- 19.5.3.4 Strategic Initiatives
- 19.5.4 QIAGEN
- 19.5.4.1 Company Overview
- 19.5.4.2 Financial Performance
- 19.5.4.3 Product Benchmarking
- 19.5.4.4 Strategic Initiatives
- 19.5.5 MERCK KGAA
- 19.5.5.1 Company Overview
- 19.5.5.2 Financial Performance
- 19.5.5.3 Product Benchmarking
- 19.5.5.4 Strategic Initiatives
- 19.5.6 HAMILTON COMPANY
- 19.5.6.1 Company Overview
- 19.5.6.2 Financial Performance
- 19.5.6.3 Product Benchmarking
- 19.5.6.4 Strategic Initiatives
- 19.5.7 BECTON, DICKINSON AND COMPANY
- 19.5.7.1 Company Overview
- 19.5.7.2 Financial Performance
- 19.5.7.3 Product Benchmarking
- 19.5.7.4 Strategic Initiatives
- 19.5.8 AVANTOR
- 19.5.8.1 Company Overview
- 19.5.8.2 Financial Performance
- 19.5.8.3 Product Benchmarking
- 19.5.8.4 Strategic Initiatives
- 19.5.9 PROMOCELL GMBH
- 19.5.9.1 Company Overview
- 19.5.9.2 Financial Performance
- 19.5.9.3 Product Benchmarking
- 19.5.9.4 Strategic Initiatives
- 19.5.10 BIOCISION
- 19.5.10.1 Company Overview
- 19.5.10.2 Financial Performance
- 19.5.10.3 Product Benchmarking
- 19.5.10.4 Strategic Initiatives
- 19.5.11 CHARLES RIVER LABORATORIES
- 19.5.11.1 Company Overview
- 19.5.11.2 Financial Performance
- 19.5.11.3 Product Benchmarking
- 19.5.11.4 Strategic Initiatives
- 19.5.12 BIOVAULT FAMILY
- 19.5.12.1 Company Overview
- 19.5.12.2 Financial Performance
- 19.5.12.3 Product Benchmarking
- 19.5.12.4 Strategic Initiatives
- 19.5.13 LONZA GROUP AG
- 19.5.13.1 Company Overview
- 19.5.13.2 Financial Performance
- 19.5.13.3 Product Benchmarking
- 19.5.13.4 Strategic Initiatives
- 19.5.14 BIO RELIANCE
- 19.5.14.1 Company Overview
- 19.5.14.2 Financial Performance
- 19.5.14.3 Product Benchmarking
- 19.5.14.4 Strategic Initiatives
- 19.5.15 STEMCELL TECHNOLOGIES INC.
- 19.5.15.1 Company Overview
- 19.5.15.2 Financial Performance
- 19.5.15.3 Product Benchmarking
- 19.5.15.4 Strategic Initiatives
- 19.5.16 BIO OUTSOURCE (SARTORIOUS)
- 19.5.16.1 Company Overview
- 19.5.16.2 Financial Performance
- 19.5.16.3 Product Benchmarking
- 19.5.16.4 Strategic Initiatives
- 19.5.17 BSL BIOSERVICE
- 19.5.17.1 Company Overview
- 19.5.17.2 Financial Performance
- 19.5.17.3 Product Benchmarking
- 19.5.17.4 Strategic Initiatives
- 19.5.18 CRYO-CELL INTERNATIONAL, INC
- 19.5.18.1 Company Overview
- 19.5.18.2 Financial Performance
- 19.5.18.3 Product Benchmarking
- 19.5.18.4 Strategic Initiatives
- 19.5.19 COVANCE
- 19.5.19.1 Company Overview
- 19.5.19.2 Financial Performance
- 19.5.19.3 Product Benchmarking
- 19.5.19.4 Strategic Initiatives
- 19.5.20 GLOBAL STEM INC.
- 19.5.20.1 Company Overview
- 19.5.20.2 Financial Performance
- 19.5.20.3 Product Benchmarking
- 19.5.20.4 Strategic Initiatives
- 19.5.21 GOODWIN BIOTECHNOLOGY INC.
- 19.5.21.1 Company Overview
- 19.5.21.2 Financial Performance
- 19.5.21.3 Product Benchmarking
- 19.5.21.4 Strategic Initiatives
- 19.5.22 SGS LIFE SCIENCES
- 19.5.22.1 Company Overview
- 19.5.22.2 Financial Performance
- 19.5.22.3 Product Benchmarking
- 19.5.22.4 Strategic Initiatives
- 19.5.23 CHINA CORD BLOOD CORPORATION
- 19.5.23.1 Company Overview
- 19.5.23.2 Financial Performance
- 19.5.23.3 Product Benchmarking
- 19.5.23.4 Strategic Initiatives
- 19.5.24 CORD BLOOD AMERICA, INC.
- 19.5.24.1 Company Overview
- 19.5.24.2 Financial Performance
- 19.5.24.3 Product Benchmarking
- 19.5.24.4 Strategic Initiatives
- 19.5.25 CBR SYSTEMS, INC.
- 19.5.25.1 Company Overview
- 19.5.25.2 Financial Performance
- 19.5.25.3 Product Benchmarking
- 19.5.25.4 Strategic Initiatives
- 19.5.26 CRYO-SAVE AG
- 19.5.26.1 Company Overview
- 19.5.26.2 Financial Performance
- 19.5.26.3 Product Benchmarking
- 19.5.26.4 Strategic Initiatives
- 19.5.27 LIFEFORCE CRYOBANKS
- 19.5.27.1 Company Overview
- 19.5.27.2 Financial Performance
- 19.5.27.3 Product Benchmarking
- 19.5.27.4 Strategic Initiatives
- 19.5.28 NATIONAL CORD BLOOD PROGRAM
- 19.5.28.1 Company Overview
- 19.5.28.2 Financial Performance
- 19.5.28.3 Product Benchmarking
- 19.5.28.4 Strategic Initiatives
- 19.5.29 VIACORD, INC.
- 19.5.29.1 Company Overview
- 19.5.29.2 Financial Performance
- 19.5.29.3 Product Benchmarking
- 19.5.29.4 Strategic Initiatives
- 19.5.30 VIRGIN HEALTH BANK
- 19.5.30.1 Company Overview
- 19.5.30.2 Financial Performance
- 19.5.30.3 Product Benchmarking
- 19.5.30.4 Strategic Initiatives
- 19.5.31 EASYDNA
- 19.5.31.1 Company Overview
- 19.5.31.2 Financial Performance
- 19.5.31.3 Product Benchmarking
- 19.5.31.4 Strategic Initiatives
- 19.5.32 DNA GENOTEK INC.
- 19.5.32.1 Company Overview
- 19.5.32.2 Financial Performance
- 19.5.32.3 Product Benchmarking
- 19.5.32.4 Strategic Initiatives
- 19.5.33 23ANDME, INC.
- 19.5.33.1 Company Overview
- 19.5.33.2 Financial Performance
- 19.5.33.3 Product Benchmarking
- 19.5.33.4 Strategic Initiatives
- 19.5.34 PROTEOGENEX
- 19.5.34.1 Company Overview
- 19.5.34.2 Financial Performance
- 19.5.34.3 Product Benchmarking
- 19.5.34.4 Strategic Initiatives
- 19.5.35 US BIOLAB CORPORATION, INC.
- 19.5.35.1 Company Overview
- 19.5.35.2 Financial Performance
- 19.5.35.3 Product Benchmarking
- 19.5.35.4 Strategic Initiatives
- 19.5.36 INFINITY BIOLOGIX
- 19.5.36.1 Company Overview
- 19.5.36.2 Financial Performance
- 19.5.36.3 Product Benchmarking
- 19.5.36.4 Strategic Initiatives
- 19.5.37 DECODE GENETICS
- 19.5.37.1 Company Overview
- 19.5.37.2 Financial Performance
- 19.5.37.3 Product Benchmarking
- 19.5.37.4 Strategic Initiatives
- 19.5.38 BROOKS LIFE SCIENCES
- 19.5.38.1 Company Overview
- 19.5.38.2 Financial Performance
- 19.5.38.3 Product Benchmarking
- 19.5.38.4 Strategic Initiatives
- 19.5.39 LGC BIOSEARCH TECHNOLOGIES
- 19.5.39.1 Company Overview
- 19.5.39.2 Financial Performance
- 19.5.39.3 Product Benchmarking
- 19.5.39.4 Strategic Initiatives
- 19.5.40 CORD BLOOD AMERICA, INC.
- 19.5.40.1 Company Overview
- 19.5.40.2 Financial Performance
- 19.5.40.3 Product Benchmarking
- 19.5.40.4 Strategic Initiatives
- 19.5.41 PREVENTIONGENETICS
- 19.5.41.1 Company Overview
- 19.5.41.2 Financial Performance
- 19.5.41.3 Product Benchmarking
- 19.5.41.4 Strategic Initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.